GUILFORD FREDERICK TIMOTHY has a total of 13 patent applications. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and measurement are HANGZHOU KUANSONG BIOTECHNOLOGY CO LTD, STEM CELL THERANOSTICS INC and JIANGXI JIMINKEXIN PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Special foods | |
#5 | Cocoa and sweets | |
#6 | Analysing materials | |
#7 | Foods | |
#8 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Guilford Frederick Timothy | 13 |
#2 | Schumm Iii Brooke | 1 |
Publication | Filing date | Title |
---|---|---|
US2021120839A1 | Low-glucose-increase chocolate confection | |
US2014271816A1 | Treatment of potential platelet aggregation with liposomally formulated glutathione and clopidogrel | |
WO2014126594A1 | Treatment of evolving bacterial resistance diseases including klebsiella pneumoniae with liposomally formulated glutathione | |
US2014023696A1 | Treatment for idiopathic pulmonary fibrosis | |
US2013202681A1 | Liposomally encapsulated reduced glutathione for management of cancer and disruption of cancer energy cycles | |
WO2013103840A1 | Anti-cancer composition and method utilizing 3-bp and liposomal reduced glutathione | |
US2012244212A1 | Enhanced method and composition for the treatment of hiv+ tuberculosis patients with anti-retroviral drugs and liposomal encapsulation for delivery of reduced glutathione |